Longeveron announces full enrollment in Phase 2b trial of laromestrocel for Hypoplastic Left Heart Syndrome, anticipating results in 2026.

First-ever mini-Heart models will be created from hypoplastic left heart syndrome (HLHS) patient stem cells, enabling personalized insights into their causes and treatments Partnership aims to ...

First-ever mini-Heart models will be created from hypoplastic left heart syndrome (HLHS) patient stem cells, enabling personalized insights into their causes and treatmentsPartnership aims to ...

Children's Hospital of Philadelphia Researchers Spotlight Adults with Hypoplastic Left Heart Syndrome (HLHS) Thriving Without Transplants Provided by PR Newswire Jun 17, 2025, 5:15:00 AM ...

Find all the latest on hypoplastic left heart syndrome at Medical Xpress. Your go-to source for news, research, and medical breakthroughs.

Long-term survival after reconstructive surgery for hypoplastic left heart syndrome. Credit: Journal of the American College of Cardiology (2025). DOI: 10.1016/j.jacc.2025.04.028 ...

Nataliya Agafonova Nataliya Agafonova, M.D., Chief Medical Officer, Longeveron Top-line trial results are anticipated in the third quarter of 2026, after the final follow-up at 12 ...

Researchers at Children's Hospital of Philadelphia (CHOP) reported long-term clinical outcomes for the largest single center cohort of individuals who underwent complex reconstructive surgery for ...

About Hypoplastic Left Heart Syndrome (HLHS) HLHS is a congenital birth defect in which the left ventricle (one of the pumping chambers of the heart) is either severely underdeveloped or missing.

A young couple have been left with no choice but to turn off their newborn baby's life support. First-time parents Oliver and ...